Vivoryon Therapeutics Company

Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Technology: Geroscience
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Halle An Der Saale, Sachsen-Anhalt, Germany
Founded Date: 1-1
Employees Number: 101-250
Funding Status: IPO
Investors Number: 1
Total Funding: $5M
Estimated Revenue: $1M to $10M
Last Funding Type: Private Equity

Visit Website
Register and Claim Ownership